Global Talent visa expansion opens new route to overseas research talent
Posted 30th September 2026 • Written by Nick Harding on thehrdirector.com • • • • • •
More than 100 UK businesses including AstraZeneca, Jaguar Land Rover, IBM, 3M and the BBC have been given greater freedom to recruit talent from overseas as part of an expansion of the Global Talent visa route.
The change, which applies specifically to people in research roles, was announced by the Government on 6 August. It gives companies with significant R&D functions greater access to international scientists, engineers and researchers. Until now, researchers using this route have largely been hosted by universities, academic institutions and independent research organisations.
The expanded list includes commercial businesses including GlaxoSmithKline, GKN Aerospace, Bristol Myers Squibb and Fujifilm Biotechnologies. It focuses on fields the Government has identified as strategically important to the UK economy. These include AWE Nuclear Security Technologies and the National Nuclear Laboratory, and quantum businesses such as Quantinuum, Oxford Quantum Circuits, Quantum Motion Technologies and Riverlane. Organisations working in renewable energy, advanced manufacturing and biotechnology are also included.
Business secretary Jonathan Reynolds said: “We’re making it easier than ever for our most innovative companies to recruit eligible researchers who will develop the medicines, technologies and industries of the future right here in the UK.”
The change specifically affects the UKRI Endorsed Funder pathway, one of the ways researchers can qualify for a Global Talent visa. In simple terms, it allows people working on approved research projects to come to the UK without having to go through the conventional employer-sponsored visa system. More than 12,500 people from over 130 countries have already come to Britain through the Endorsed Funder pathway, according to the Government. The new commercial addictions mean that number is expected to grow significantly.
Professor Christopher Smith, UKRI’s International, Talent and Skills Champion, said extending the visa to businesses would allow the benefits to be felt “in a wide range of sectors, from medicines and AI to the creative and cultural economy”.
Unlike the Skilled Worker visa, Global Talent route immigration status is not tied to one employer. Holders can change jobs without seeking fresh immigration permission and can be employed, self-employed or establish their own business.
The Government hopes this freedom will make the UK more attractive to internationally mobile researchers who have several countries competing for their skills, as Yash Dubal, director of visa specialist A Y & J Solicitors explains.
“This is an important change because it brings the Global Talent route much more firmly into the commercial world,” he says. “Some of the most innovative research in the UK is happening inside businesses. Giving more companies access to the route should make it easier for them to compete internationally for specialist researchers and engineers, particularly in areas where the talent pool is already very limited.”
For international businesses, however, Global Talent is only one option.
Overseas companies with UK offices considering bringing people into Britain can use Global Business Mobility (GBM) routes if they want to transfer an existing employee rather than recruit afresh. For example, the Senior or Specialist Worker route allows an overseas employer to transfer an existing senior manager or specialist to a linked UK operation, subject to sponsorship, eligibility and salary requirements.
“Employers should consider whether they are transferring an existing worker or recruiting internationally; whether the assignment is temporary or long term; whether the person qualifies for Global Talent; and whether the flexibility offered by Global Talent outweighs the greater control associated with sponsorship,” continues Mr Dubal.
The pharmaceutical industry has already welcomed the latest change.
Oliver Buckley-Mellor, senior policy manager at the Association of the British Pharmaceutical Industry, said the potential of Global Talent to boost British science and economic growth had previously not been fully realised.
“By opening the endorsed funder route to research-intensive businesses, including several ABPI members, the government is helping to address a key gap in our global talent offer,” he said.
The Government argues the benefits should extend beyond the overseas workers being recruited. Bringing specialist researchers into commercial R&D teams, it says, will enable more cutting-edge projects to be carried out in Britain, supporting skilled jobs for UK workers and helping companies grow without having to move research elsewhere.
All of the R&D companies included in the expansion operate within the eight high-growth sectors identified in the Government’s Modern Industrial Strategy, including advanced manufacturing, digital and technologies, clean energy, life sciences and the creative industries.
The need is particularly acute in emerging industries where businesses can find themselves competing internationally for a relatively small number of specialists.
Jonathan Legh-Smith, executive director of UKQuantum, said: “Attracting world-class international talent is critical to sustaining the UK’s momentum in quantum.”
The changes would strengthen the ability of high-growth quantum businesses operating in the UK to attract expertise from around the world, he added.
The biotech industry has also welcomed the expansion. Kate Barclay MBE, skills consultant at the BioIndustry Association, said the UK’s ability to compete internationally depended on “attracting and retaining the very best”.
She said giving life sciences and biotech businesses access to the expanded route would help them secure the specialist skills and international experience they need to grow.
The Government is also planning to widen its Future Technology Research and Innovation scheme, expanding it to more R&D businesses in priority areas including AI, quantum technology and engineering biology. The scheme allows companies to host overseas researchers, scientists, interns and technical specialists for research, training and work placements lasting up to two years.
It forms part of a wider attempt to make Britain more attractive to internationally mobile researchers. The Government has established a £54 million Global Talent Fund to bring research leaders to the UK, with 18 researchers recruited so far to work in areas linked to its Industrial Strategy.
A separate Global Talent Taskforce has also been established to identify leading international talent and encourage them to move to Britain, supported by a dedicated concierge service.
The latest visa expansion follows changes introduced in April which widened the Global Talent fast-track academic appointments route. The Government says the combined measures are intended to attract people at different stages of their careers, from researchers showing high potential early in their careers to established international research leaders.
To read original article click here